AptarGroup Inc (ATR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
AptarGroup Inc stock (ATR) is currently trading at $125.82. AptarGroup Inc PE ratio is 21.11. AptarGroup Inc PS ratio (Price-to-Sales) is 2.16. Analyst consensus price target for ATR is $163.00. WallStSmart rates ATR as Underperform.
- ATR PE ratio analysis and historical PE chart
- ATR PS ratio (Price-to-Sales) history and trend
- ATR intrinsic value — DCF, Graham Number, EPV models
- ATR stock price prediction 2025 2026 2027 2028 2029 2030
- ATR fair value vs current price
- ATR insider transactions and insider buying
- Is ATR undervalued or overvalued?
- AptarGroup Inc financial analysis — revenue, earnings, cash flow
- ATR Piotroski F-Score and Altman Z-Score
- ATR analyst price target and Smart Rating
AptarGroup Inc
📊 No data available
Try selecting a different time range
ATR Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · AptarGroup Inc (ATR)
ATR trades 250% above its Graham fair value of $39.98, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
AptarGroup Inc (ATR) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around peg ratio and eps growth. Fundamentals are solid but monitor weak areas for improvement.
AptarGroup Inc (ATR) Key Strengths (3)
95.61% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Solid profitability: $15 profit per $100 equity
Supporting Valuation Data
AptarGroup Inc (ATR) Areas to Watch (7)
Earnings declining -23.50%, profits shrinking
Very expensive relative to growth, significant premium
Thin operating margins with cost pressures present
Revenue is fairly priced at 2.16x sales
Fairly priced relative to book value
Solid revenue growth at 13.50% per year
Decent profitability, keeps $10 per $100 revenue
AptarGroup Inc (ATR) Detailed Analysis Report
Overall Assessment
This company scores 53/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 3 register as strengths (avg 8.0/10) while 7 fall into concern territory (avg 4.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap, Return on Equity. Profitability is solid with Return on Equity at 15.10%.
The Bear Case
The primary concerns are EPS Growth, PEG Ratio, Operating Margin. Some valuation metrics including PEG Ratio (3.06), Price/Sales (2.16), Price/Book (2.92) suggest expensive pricing. Growth concerns include Revenue Growth at 13.50%, EPS Growth at -23.50%, which may limit upside. Profitability pressure is visible in Operating Margin at 11.30%, Profit Margin at 10.40%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 15.10% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 13.50% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Institutional Own., Market Cap) and negatives (EPS Growth, PEG Ratio). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ATR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ATR's Price-to-Sales ratio of 2.16x trades at a 20% premium to its historical average of 1.8x (73th percentile). The current valuation is 29% below its historical high of 3.04x set in Apr 2007, and 148% above its historical low of 0.87x in Feb 2009. Over the past 12 months, the PS ratio has compressed from ~2.5x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for AptarGroup Inc (ATR) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
AptarGroup Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 3.8B with 14% growth year-over-year. Profit margins of 10.4% are healthy, with room for further expansion as the business scales.
Key Findings
Generating 97M in free cash flow and 184M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can AptarGroup Inc push profit margins above 15% as the business scales?
Debt management: total debt of 1.5B is significantly higher than cash (402M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact AptarGroup Inc.
Bottom Line
AptarGroup Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(50 last 3 months)
| Insider | Type | Shares |
|---|---|---|
TOUYA, GAEL Segment President | Sell | -335 |
| Insider | Type | Shares |
|---|---|---|
TOUYA, GAEL Segment President | Buy | +1,125 |
| Insider | Type | Shares |
|---|---|---|
TOUYA, GAEL Segment President | Sell | -3,500 |
| Insider | Type | Shares |
|---|---|---|
PRIEUR, MARC Segment President | Sell | -2,000 |
Data sourced from SEC Form 4 filings
Last updated: 10:05:46 AM
About AptarGroup Inc(ATR)
NYSE
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
AptarGroup, Inc. offers a range of packaging, dispensing and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectables, and food and beverage markets. The company is headquartered in Crystal Lake, Illinois.